High Tech Pharm Co., Ltd. (KOSDAQ: 106190)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,740
-230 (-1.65%)
Sep 11, 2024, 2:32 PM KST
24.53%
Market Cap 145.04B
Revenue (ttm) 83.50B
Net Income (ttm) 13.52B
Shares Out 10.63M
EPS (ttm) 1,910.97
PE Ratio 7.14
Forward PE n/a
Dividend 100.00 (0.72%)
Ex-Dividend Date n/a
Volume 17,789
Open 14,150
Previous Close 13,970
Day's Range 13,700 - 14,480
52-Week Range 7,880 - 19,280
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 8, 2024

About High Tech Pharm

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 65
Stock Exchange KOSDAQ
Ticker Symbol 106190
Full Company Profile

Financial Performance

In 2023, High Tech Pharm's revenue was 76.77 billion, a decrease of -25.43% compared to the previous year's 102.95 billion. Earnings were 8.08 billion, an increase of 37.52%.

Financial Statements

News

There is no news available yet.